Selected Experience
Judgment carries more weight when it has been tested in the operating seat.
SVI's perspective is grounded in executive responsibility across pharmaceuticals, biotechnology, diagnostics, nuclear medicine, regulatory, and medical devices. Experience includes transactions, P&L ownership, R&D, regulatory, commercialization, manufacturing considerations, market access, portfolio strategy, and operating transformation.
Transaction and portfolio leadership
$10.4B+ in acquisitions and portfolio activity
Senior corporate development leadership at a global specialty pharmaceutical company, across strategic assessments, acquisitions, divestitures, partnerships, alliances, and portfolio transformation.
Oncology
From strategy through development and commercialization
Experience building oncology growth platforms, advancing development programs and clinical trials, leading cross-functional teams, developing companion diagnostic strategies, and forming external alliances.
Radiopharmaceuticals and nuclear medicine
Experience across development, operations, supply, and commercialization
Experience includes nuclear medicine and radiopharmaceutical R&D, manufacturing considerations, supply and logistics, regulatory compliance, commercialization, portfolio strategy, and operating economics. This experience provides a perspective that extends beyond clinical opportunity into the practical requirements needed to deliver that opportunity reliably and at scale.
Medical devices
Strategy translated into transaction and operating value
Senior corporate-strategy leadership for a $1.2B pharmaceutical and medical device business, including origination of the strategic case behind a $2.6B peripheral vascular medical device transaction.
Diagnostics
Commercial growth, market access, and transaction experience
At a point-of-care diagnostics company, commercial restructuring preceded significant revenue growth and a successful sale process. At a global in vitro diagnostics company, commercial-model and distributor changes supported renewed growth and profitability across North and Latin America. Created and implemented healthcare economics programs to support reimbursement and adoption.
Market access
Payer strategy with operating consequences
Earlier diagnostics leadership included integrated-health-system, GPO, and disease-management programs associated with more than $100M of new revenue.
CEO leadership
Responsibility beyond the recommendation
As CEO of an early-stage immuno-oncology company, led corporate strategy, R&D and clinical direction, regulatory planning, and partnerships.
SVI advisory work
Strategic Value Inflections has supported strategy and portfolio decisions, buy-side and sell-side work, valuation and diligence, market access, commercialization, capital strategy, and strategic alliances for life-sciences companies and investors.
Confidentiality: All of SVI's advisory work is confidential. Client-specific examples are shared only where appropriate and authorized.